Peter Joyce, Grey Wolf Therapeutics co-founder and CEO

Grey Wolf reels in $49M to en­ter the clin­ic for new im­munother­a­py tar­get

When he finds the time to go fly fish­ing, Pe­ter Joyce says gray wulffs, or mayfly mim­ics, are his good luck charm — he al­ways catch­es a fish when he us­es them. Joyce has now brought in $49 mil­lion in a Se­ries B round for his biotech com­pa­ny Grey Wolf Ther­a­peu­tics.

The Ox­ford, UK can­cer biotech plans to use the funds to bring its first as­set in­to hu­man tri­als in the com­ing month or two, ac­cord­ing to Joyce. Pfiz­er Ven­tures and Early­bird Ven­ture Cap­i­tal co-led the round, which the start­up dis­closed Thurs­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.